LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
01 1LGM Pharma
02 1DKSH
03 1HRV Global Life Sciences
04 1Nortec Quimica
05 1Arene Lifesciences
06 1Aurobindo Pharma Limited
07 1Aurore Life Sciences
08 1Blanver
09 1Cambrex Corporation
10 1Chromo Laboratories
11 2Cipla
12 1Dasami Lab
13 1Emcure Pharmaceuticals
14 1Gilead Sciences
15 1Guangzhou Tosun Pharmaceutical
16 1HONOUR LAB LTD
17 3Hetero Drugs
18 1Laurus Labs
19 1Lupin Ltd
20 1Macleods Pharmaceuticals Limited
21 1Mangalam Drugs & Organics Ltd
22 1RANBAXY LABORATORIES LIMITED
23 1Shanghai Desano Bio-Pharmaceutical
24 1Shijiazhuang Lonzeal Pharmac.Co. ltd
25 3Viatris
26 1Vivin Drugs
01 2Brazil
02 3China
03 19India
04 1Switzerland
05 6U.S.A
01 13Active
02 4Inactive
03 14Blank
01 31Blank
01 1229MF10061
02 1229MF10167
03 29Blank
01 1WC-0016
02 1WC-0023
03 1WC-0041
04 1WC-0065
05 1WC-0065a
06 1WC-0079
07 2WC-0117
08 1WC-0119
09 1WC-0140
10 1WC-0141
11 1WC-0201
12 1WC-0213
13 1WC-0473
14 1WC-0578
15 16Blank
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-05-28
Pay. Date : 2015-05-14
DMF Number : 21612
Submission : 2008-05-09
Status : Active
Type : II
Date of Issue : 2022-09-16
Valid Till : 2025-08-08
Written Confirmation Number : WC-0041
Address of the Firm :
NDC Package Code : 68554-0027
Start Marketing Date : 2003-07-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-05-16
Pay. Date : 2019-02-27
DMF Number : 33068
Submission : 2018-10-04
Status : Active
Type : II
Date of Issue : 2019-08-16
Valid Till : 2022-08-15
Written Confirmation Number : WC-0065
Address of the Firm :
NDC Package Code : 68554-0027
Start Marketing Date : 2003-07-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25001
Submission : 2011-05-31
Status : Active
Type : II
Date of Issue : 2019-11-28
Valid Till : 2022-07-02
Written Confirmation Number : WC-0079
Address of the Firm :
NDC Package Code : 33342-500
Start Marketing Date : 2015-11-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-12-01
Pay. Date : 2017-10-11
DMF Number : 20708
Submission : 2007-07-18
Status : Active
Type : II
Date of Issue : 2019-06-26
Valid Till : 2022-06-25
Written Confirmation Number : WC-0023
Address of the Firm :
NDC Package Code : 65862-305
Start Marketing Date : 2024-01-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 34105
Submission : 2019-10-17
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-05-24
Pay. Date : 2014-03-19
DMF Number : 19785
Submission : 2006-09-22
Status : Active
Type : II
Date of Issue : 2022-06-03
Valid Till : 2025-07-02
Written Confirmation Number : WC-0140
Address of the Firm :
NDC Package Code : 53104-7637
Start Marketing Date : 2016-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-11-05
Pay. Date : 2013-02-07
DMF Number : 25617
Submission : 2011-12-19
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-05-21
Pay. Date : 2013-05-14
DMF Number : 19566
Submission : 2006-06-30
Status : Active
Type : II
Date of Issue : 2022-06-22
Valid Till : 2025-07-28
Written Confirmation Number : WC-0117
Address of the Firm :
NDC Package Code : 65015-827
Start Marketing Date : 2013-06-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-02-05
Pay. Date : 2013-09-20
DMF Number : 27455
Submission : 2013-09-24
Status : Active
Type : II
Date of Issue : 2022-06-22
Valid Till : 2025-07-28
Written Confirmation Number : WC-0117
Address of the Firm :
NDC Package Code : 65015-827
Start Marketing Date : 2013-06-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-03-23
Pay. Date : 2017-03-01
DMF Number : 31457
Submission : 2017-03-10
Status : Active
Type : II
Date of Issue : 2019-06-26
Valid Till : 2022-06-25
Written Confirmation Number : WC-0016
Address of the Firm :
NDC Package Code : 65015-827
Start Marketing Date : 2013-06-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32096
Submission : 2017-11-15
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-05-09
Pay. Date : 2013-04-17
DMF Number : 23773
Submission : 2010-04-28
Status : Active
Type : II
Date of Issue : 2023-07-03
Valid Till : 2025-07-02
Written Confirmation Number : WC-0213
Address of the Firm :
NDC Package Code : 42385-304
Start Marketing Date : 2010-04-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Aging Life Science Co., Ltd.
Registration Date : 2020-07-15
Registration Number : Su434-17-ND
Manufacturer Name : Laurus Labs Limited(Unit-3)
Manufacturer Address : Plot No. 18, Jawaharlal Nehru Pharma City, Parawada, Visakhapatnam - 531 021, Andhra Pradesh, India
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-10-10
Pay. Date : 2013-02-04
DMF Number : 22944
Submission : 2009-09-18
Status : Active
Type : II
Registration Number : 229MF10167
Registrant's Address : Kalpataru Inspire, 3rd Floor, Off Western Express Highway, Santacruz (East), Mumbai 400055, India
Initial Date of Registration : 2017-08-22
Latest Date of Registration : --
Date of Issue : 2022-09-30
Valid Till : 2025-09-10
Written Confirmation Number : WC-0201
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24975
Submission : 2011-05-18
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 28505
Submission : 2014-08-04
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23184
Submission : 2009-10-16
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21706
Submission : 2008-06-17
Status : Inactive
Type : II
Date of Issue : 2019-08-16
Valid Till : 2022-08-15
Written Confirmation Number : WC-0065a
Address of the Firm :
NDC Package Code : 68554-0027
Start Marketing Date : 2003-07-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registration Number : 229MF10061
Registrant's Address : 1021 Hayter Road Edmonton, Alberta T6S 1A1, Canada
Initial Date of Registration : 2017-03-07
Latest Date of Registration : --
Date of Issue : 2024-02-19
Valid Till : 2027-02-19
Written Confirmation Number : WC-0578
Address of the Firm :
NDC Package Code : 70966-0024
Start Marketing Date : 2003-07-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Date of Issue : 2020-06-11
Valid Till : 2023-06-10
Written Confirmation Number : WC-0473
Address of the Firm :
Date of Issue : 2019-06-26
Valid Till : 2019-07-07
Written Confirmation Number : WC-0141
Address of the Firm :
NDC Package Code : 53104-7637
Start Marketing Date : 2016-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59116-7480
Start Marketing Date : 2014-09-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Emtricitabine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Emtricitabine, including repackagers and relabelers. The FDA regulates Emtricitabine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Emtricitabine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Emtricitabine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Emtricitabine supplier is an individual or a company that provides Emtricitabine active pharmaceutical ingredient (API) or Emtricitabine finished formulations upon request. The Emtricitabine suppliers may include Emtricitabine API manufacturers, exporters, distributors and traders.
click here to find a list of Emtricitabine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 26 companies offering Emtricitabine
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?